Daniel Chan

1.4k total citations
29 papers, 523 citations indexed

About

Daniel Chan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Daniel Chan has authored 29 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Daniel Chan's work include Heart Failure Treatment and Management (9 papers), Acute Myocardial Infarction Research (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Daniel Chan is often cited by papers focused on Heart Failure Treatment and Management (9 papers), Acute Myocardial Infarction Research (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Daniel Chan collaborates with scholars based in New Zealand, United States and United Kingdom. Daniel Chan's co-authors include Nauder Faraday, Lauren J. Kim, George M. Williams, Peter J. Pronovost, Todd Dorman, Lee A. Fleisher, Emilio A. Martı́nez, Bruce A. Perler, Regent Lee and Andrew Kerr and has published in prestigious journals such as Circulation, Nature Communications and Annals of Surgery.

In The Last Decade

Daniel Chan

21 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Chan New Zealand 9 233 138 117 99 72 29 523
James R. Priest United States 14 172 0.7× 100 0.7× 57 0.5× 361 3.6× 14 0.2× 29 868
Peter Johnston New Zealand 21 56 0.2× 411 3.0× 87 0.7× 176 1.8× 21 0.3× 53 1.2k
Jan M. Nielsen Denmark 13 285 1.2× 76 0.6× 122 1.0× 136 1.4× 170 2.4× 21 602
Sofia Cividini United Kingdom 10 49 0.2× 50 0.4× 62 0.5× 191 1.9× 28 0.4× 15 759
J. J. van der Meer Netherlands 9 88 0.4× 70 0.5× 37 0.3× 116 1.2× 31 0.4× 15 763
E. Sanz Spain 10 298 1.3× 93 0.7× 61 0.5× 99 1.0× 187 2.6× 24 643
María Victoria Monsalve Canada 15 282 1.2× 177 1.3× 35 0.3× 149 1.5× 3 0.0× 31 782
Haixia Zhang China 14 22 0.1× 29 0.2× 30 0.3× 43 0.4× 243 3.4× 59 552
Athanasios Charalampopoulos United Kingdom 18 523 2.2× 106 0.8× 534 4.6× 34 0.3× 96 1.3× 66 966
Ian Kirkwood Australia 11 105 0.5× 96 0.7× 155 1.3× 37 0.4× 178 2.5× 31 576

Countries citing papers authored by Daniel Chan

Since Specialization
Citations

This map shows the geographic impact of Daniel Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Chan more than expected).

Fields of papers citing papers by Daniel Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Chan. The network helps show where Daniel Chan may publish in the future.

Co-authorship network of co-authors of Daniel Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Chan. A scholar is included among the top collaborators of Daniel Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Chan. Daniel Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chan, Daniel, Robert N. Doughty, Mayanna Lund, et al.. (2024). https://nzmj.org.nz/journal/vol-137-no-1599/use-of-medications-for-migraine-in-aotearoa-new-zealand. New Zealand Medical Journal. 137(1599). 88–102.
3.
Doughty, Robert N., Gerry Devlin, Selwyn Wong, et al.. (2024). 2023 position statement on improving management for patients with heart failure in Aotearoa New Zealand. New Zealand Medical Journal. 137(1590). 93–99.
4.
Chan, Daniel, et al.. (2024). Short, Medium and Long-Term Cause-Specific Mortality Following First-Ever Heart Failure Hospitalisation in New Zealand. Heart Lung and Circulation. 33(10). 1475–1483.
5.
Kerr, Andrew, et al.. (2023). What is the Statin Possession Ratio Cut-Off Which Identifies Those at Increased Risk Following Acute Coronary Syndrome (ANZACS-QI 68)?. Heart Lung and Circulation. 32(4). 487–496. 4 indexed citations
6.
Chan, Daniel, Corina Grey, Robert N. Doughty, et al.. (2023). Widening ethnic inequities in heart failure incidence in New Zealand. Heart. 110(4). 281–289. 4 indexed citations
7.
Doughty, Robert N., Vanessa Selak, Katrina Poppe, et al.. (2022). Identification of clinically relevant cohorts of people with heart failure from electronic health data in Aotearoa: potential, pitfalls and a plan. New Zealand Medical Journal. 135(1563). 96–104.
8.
Chan, Daniel, Andrew Kerr, Corina Grey, et al.. (2021). Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006–2018. Heart. 108(4). 300–306. 11 indexed citations
9.
Chan, Daniel, Andrew Kerr, & Robert N. Doughty. (2021). Temporal trends in the burden of heart failure. Internal Medicine Journal. 51(8). 1212–1218. 17 indexed citations
10.
Chan, Daniel, Robert N. Doughty, Mayanna Lund, et al.. (2021). Prognostic significance of mid-range ejection fraction following acute coronary syndrome (ANZACS-QI 23).. New Zealand medical journal. 134(1528). 57–78. 2 indexed citations
11.
Chan, Daniel, Robert N. Doughty, Mayanna Lund, Mildred Lee, & Andrew Kerr. (2020). Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34). Heart Lung and Circulation. 29(9). 1386–1396.
12.
13.
Chan, Daniel, et al.. (2020). Heart failure clinics improve use of evidence-based heart failure therapies in patients with reduced ejection fraction following acute coronary syndrome (ANZACS-QI 48).. PubMed. 133(1516). 58–71. 1 indexed citations
14.
Pan, Jianbo, Yingwei Hu, Shisheng Sun, et al.. (2020). Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer. Nature Communications. 11(1). 6139–6139. 90 indexed citations
15.
Wang, Tom Kai Ming, et al.. (2019). Percutaneous Coronary Intervention for Left Main Coronary Disease in New Zealand: National Linkage Study of Characteristics and In-Hospital Outcomes (ANZACS-QI 38). Cardiovascular revascularization medicine. 21(5). 573–579. 1 indexed citations
16.
Chan, Daniel, et al.. (2019). What is the Optimal Rate of Invasive Coronary Angiography After Acute Coronary Syndrome? (ANZACS-QI 22). Heart Lung and Circulation. 29(2). 262–271. 4 indexed citations
17.
18.
Olsson, Tina M., Daniel Chan, James D. Johnson, & Avina Paranjpe. (2017). In-vivo microbiologic evaluation of polytetrafluoroethylene and cotton as endodontic spacer materials.. PubMed. 609–614. 8 indexed citations
19.
Okosieme, Onyebuchi, Daniel Chan, Sarah Price, John H. Lazarus, & Lakdasa Premawardhana. (2009). The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. Clinical Endocrinology. 72(1). 122–127. 28 indexed citations
20.
Kim, Lauren J., Emilio A. Martı́nez, Nauder Faraday, et al.. (2002). Cardiac Troponin I Predicts Short-Term Mortality in Vascular Surgery Patients. Circulation. 106(18). 2366–2371. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James R. Priest Breakdown of academic impact, for papers by Peter Johnston Breakdown of academic impact, for papers by Jan M. Nielsen Breakdown of academic impact, for papers by Sofia Cividini Breakdown of academic impact, for papers by J. J. van der Meer Breakdown of academic impact, for papers by E. Sanz Breakdown of academic impact, for papers by María Victoria Monsalve Breakdown of academic impact, for papers by Haixia Zhang Breakdown of academic impact, for papers by Athanasios Charalampopoulos Breakdown of academic impact, for papers by Ian Kirkwood
Rankless by CCL
2026